Thermo Fisher Scientific Inc. (TMO) Shares Sold by Ontario Teachers Pension Plan Board

Ontario Teachers Pension Plan Board trimmed its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 4.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 284,409 shares of the medical research company’s stock after selling 13,364 shares during the period. Thermo Fisher Scientific makes up about 0.7% of Ontario Teachers Pension Plan Board’s portfolio, making the stock its 25th largest holding. Ontario Teachers Pension Plan Board’s holdings in Thermo Fisher Scientific were worth $54,004,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. BlackRock Inc. increased its holdings in shares of Thermo Fisher Scientific by 1.6% in the second quarter. BlackRock Inc. now owns 23,355,469 shares of the medical research company’s stock valued at $4,074,828,000 after buying an additional 366,584 shares in the last quarter. Nicholas Company Inc. increased its holdings in shares of Thermo Fisher Scientific by 0.3% in the second quarter. Nicholas Company Inc. now owns 594,944 shares of the medical research company’s stock valued at $103,799,000 after buying an additional 1,540 shares in the last quarter. Amalgamated Bank increased its holdings in shares of Thermo Fisher Scientific by 57.0% in the second quarter. Amalgamated Bank now owns 44,921 shares of the medical research company’s stock valued at $7,837,000 after buying an additional 16,308 shares in the last quarter. BlueMountain Capital Management LLC raised its stake in Thermo Fisher Scientific by 54.7% during the 2nd quarter. BlueMountain Capital Management LLC now owns 4,999 shares of the medical research company’s stock valued at $872,000 after purchasing an additional 1,768 shares during the period. Finally, Investment Centers of America Inc. raised its stake in Thermo Fisher Scientific by 1.6% during the 2nd quarter. Investment Centers of America Inc. now owns 1,317 shares of the medical research company’s stock valued at $230,000 after purchasing an additional 21 shares during the period. Hedge funds and other institutional investors own 86.54% of the company’s stock.

Several brokerages have issued reports on TMO. Leerink Swann reissued an “outperform” rating and set a $200.00 target price (down from $216.00) on shares of Thermo Fisher Scientific in a research note on Monday, December 4th. Morgan Stanley boosted their target price on shares of Thermo Fisher Scientific from $223.00 to $227.00 and gave the company an “overweight” rating in a research note on Thursday, February 1st. BTIG Research began coverage on shares of Thermo Fisher Scientific in a research note on Friday, January 5th. They set a “buy” rating and a $230.00 target price on the stock. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “sell” rating to a “hold” rating in a research note on Saturday, January 20th. Finally, Barclays boosted their target price on shares of Thermo Fisher Scientific from $225.00 to $245.00 and gave the company an “overweight” rating in a research note on Thursday, February 1st. Two equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $220.50.

In other news, CEO Marc N. Casper sold 50,000 shares of the company’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $191.74, for a total value of $9,587,000.00. Following the transaction, the chief executive officer now directly owns 302,577 shares of the company’s stock, valued at $58,016,113.98. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Stephen Williamson sold 5,000 shares of the company’s stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $209.26, for a total transaction of $1,046,300.00. Following the completion of the transaction, the chief financial officer now directly owns 30,741 shares in the company, valued at $6,432,861.66. The disclosure for this sale can be found here. Insiders sold 94,327 shares of company stock worth $19,260,542 over the last ninety days. 0.49% of the stock is currently owned by company insiders.

Thermo Fisher Scientific Inc. (NYSE:TMO) opened at $210.61 on Monday. Thermo Fisher Scientific Inc. has a one year low of $151.74 and a one year high of $226.44. The company has a quick ratio of 0.92, a current ratio of 1.35 and a debt-to-equity ratio of 0.74. The firm has a market cap of $84,453.64, a price-to-earnings ratio of 22.22, a PEG ratio of 1.54 and a beta of 1.11.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Wednesday, January 31st. The medical research company reported $2.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.66 by $0.13. Thermo Fisher Scientific had a net margin of 10.64% and a return on equity of 16.01%. The business had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $5.72 billion. During the same period in the prior year, the business posted $2.41 earnings per share. Thermo Fisher Scientific’s revenue for the quarter was up 22.1% compared to the same quarter last year. research analysts predict that Thermo Fisher Scientific Inc. will post 10.81 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, April 16th. Stockholders of record on Thursday, March 15th will be paid a $0.17 dividend. The ex-dividend date of this dividend is Wednesday, March 14th. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.32%. Thermo Fisher Scientific’s dividend payout ratio is 10.71%.

COPYRIGHT VIOLATION NOTICE: “Thermo Fisher Scientific Inc. (TMO) Shares Sold by Ontario Teachers Pension Plan Board” was first reported by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://stocknewstimes.com/2018/02/19/thermo-fisher-scientific-inc-tmo-shares-sold-by-ontario-teachers-pension-plan-board.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply